Compounded tirzepatide recalled after FDA warning

A compounded version of Eli Lilly's injectable weight-loss and diabetes therapy tirzepatide has been recalled from sale due to sterility concerns.

Product Complaints & Recalls Virtual Summit

Deliver an Integrated Product Complaint System

Allergan pulls breast implants after link to rare cancer

The challenge of transparency in the global supply chain

In the past year the pharmaceutical industry has witnessed an unprecedented number of drug recalls following the discovery that these products contained impurities, some of which are life t